Mushrooms have long been recognized for their nutritional and medicinal properties, but their potential as sources of antimicrobial agents remains underexplored. This study investigates the antimicrobial activity of various wild mushroom species against selected bacterial and fungal pathogens. Specifically, the study focused on the inhibition zones of Staphylococcus aureus, Escherichia coli, Candida albicans, Fusarium oxysporum, and Fusarium proliferatum when exposed to extracts from twelve different mushroom species, including Schizophyllum commune, Laeiporus sulphureus, Pleurotus pulmonarius, and others. The results revealed significant antibacterial and antifungal activities, with Schizophyllum commune showing the highest inhibition against Fusarium oxysporum (71.42 ± 0.28 mm) and Microporus xanthopus demonstrating strong inhibition against Staphylococcus aureus (8.46 ± 0.11 mm). Additionally, Pleurotus sajor-caju exhibited notable antifungal activity against Fusarium proliferatum (76.06 ± 0.14 mm), suggesting its potential as a source of novel antifungal compounds. The study observed a varied range of inhibition zones across different mushroom species, emphasizing the diverse antimicrobial potential within mushroom mycoflora. These findings underscore the importance of further research into the bioactive compounds of mushrooms, which could contribute to the development of new antimicrobial agents. The study not only highlights the significance of mushrooms in combating microbial resistance but also opens avenues for their inclusion in future pharmaceutical applications.
Published in | Chemical and Biomolecular Engineering (Volume 9, Issue 4) |
DOI | 10.11648/j.cbe.20240904.11 |
Page(s) | 52-61 |
Creative Commons |
This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited. |
Copyright |
Copyright © The Author(s), 2024. Published by Science Publishing Group |
Antibacterial, Antifungal, Inhibition Zone, Macrofungi, Medicinal Property
[1] | Singh B, Singh VK. (2023a) Characterization and nutritional analysis of cultivable wild edible Mushrooms collected from District Ayodhya (U. P.), India. International Journal of Biological Innovations 5(1): 170-175. |
[2] | Bains A, Tripathi A. (2016) Antimicrobial and Antioxidant Activity of Aqueous Extract of Six Mushrooms Collected from Himachal Pradesh. International Journal of Biology, Pharmacy and Allied Science 5(7): 1717-1728. |
[3] | Adeoyo OR, Oluborode OO. (2020) Antimicrobial properties of some Nigerian edible mushrooms. The Journal of Phytopharmacology 9(2): 110-114. |
[4] | Singh B, Singh V. K. (2022) Macrofungal (mushroom) diversity of Uttar Pradesh, India. International Research Journal of Modernization in Engineering Technology and Science 4(8): 208-217. |
[5] | Sagar A, Kumar S, Kamal S, Rana J. (2022) Studies on evaluation of antibacterial activities of some cultivated mushrooms against human pathogenic bacteria. Mushroom Research 31(1): 81-91. |
[6] | Ramesh C, Pattar MG. (2010) Antimicrobial properties, antioxidant activity and bioactive compounds from six wild edible mushrooms of western ghats of Karnataka, India. Pharmacognosy Research 2(2): 107-112. |
[7] | Waithaka PN, Gathuru EM, Githaiga BM, et al. (2017) Antimicrobial Activity of Mushroom (Agaricus bisporus) and Fungal (Trametes gibbosa) Extracts from Mushrooms and Fungi of Egerton Main Campus, Njoro Kenya. J Biomedical Sci. 6: 3. |
[8] | Singh B, Singh VK. (2023b) Molecular Characterization and Biochemical Analysis of Schizophyllum Commune from Ayodhya, India. Universe International Journal of Interdisciplinary Research 3(11): 11-19. |
[9] | Lima CUJO, Gris EF, Karnikowski MGO. (2016) Antimicrobial properties of the mushroom Agaricus blazei – integrative review. Brazilian Journal of Pharmacognosy 26: 780-786. |
[10] | Jha P, Saraf A, Sohal JK. (2021) Antimicrobial Activity of Biologically Synthesized Gold Nanoparticles from Wild Mushroom, Cantharellus Species. Journal of Scientific Research 65(3): 78-83. |
[11] | Bains A, Sharma A, Tripathi A. (2015) Antibacterial and Antioxidant Properties of Wild Mushrooms collected from Himachal Pradesh. International Journal of Biology, Pharmacy and Allied Sciences 4(10): 6161-6170. |
[12] | Asgharpour F, Moghadamnia AA, Alizadeh Y, Kazemi S. (2020) Chemical Composition and antibacterial activity of hexane extract of Lycoperdon Pyriforme. South African Journal of Botany 131: 195-199. |
[13] | Sevindik M. (2018) Investigation of Antioxidant/Oxidant Status and Antimicrobial Activities of Lentinus tigrinus, Advances in Pharmacological Sciences. Volume 2018, Article ID 1718025, 4 pages. |
[14] | Khumlianlal J, Sharma KC, Singh LM, Mukherjee PK, Indira S. (2022) Nutritional Profiling and Antioxidant Property of Three Wild Edible Mushrooms from North East India. Molecules 27: 5423. |
[15] | Goswami S, Rahman I, Kishor S, Dwivedi SK. (2020) Evaluation of Antibacterial Potential of Daldinia Concentrica from North Eastern Region of India. Defence Life Science Journal 5(2): 74-79. |
[16] | Janeš D, Kreft S, Jurc M, Seme K, Štrukelj B. (2007) Antibacterial Activity in Higher Fungi (Mushrooms) and Endophytic Fungi from Slovenia. Pharmaceutical Biology 45(9): 700-706. |
[17] | Sitati CNW, Ogila KO, Waihenya RW, Ochola LA. (2021) Phytochemical Profile and Antimicrobial Activities of Edible Mushroom Termitomyces striatus. Evidence-Based Complementary and Alternative Medicine, Volume 2021, Article ID 3025848, 10 pages. |
[18] | Kim JH, Tam CC, Chan KL, Mahoney N, Cheng LW, Friedman M, Land KM. (2022) Antimicrobial Efficacy of Edible Mushroom Extracts: Assessment of Fungal Resistance. Appl. Sci. 12: 4591. |
[19] | Lallawmsanga, Passari AK, Mishra VK, Leo VV, Singh BP, Meyyappan GV, Gupta VK, Uthandi S, Upadhyay RC. (2016) Antimicrobial potential, identification and phylogenetic affiliation of wild mushrooms from two sub-tropical semievergreen Indian forest ecosystems. PLOS ONE 11(11): e0166368. |
[20] | Roy Das A, Saha AK, Das P. (2017) Proximate composition and antimicrobial activity of three wild edible mushrooms consumed by ethnic inhabitants of Tripura in northeast India. Studies in Fungi 2(1): 17–25. |
[21] | Kristensen HL, Rosenqvist E, Jakobsen J. (2012) Increase of vitamin D2 by UV-B exposure during the growth phase of white button mushroom (Agaricus bisporus). Food Nutr Res 56: 1-7. |
[22] | Sliva D, Loganathan J, Jiang J, Jedinak A, Lamb JG, Terry C, Baldridge LA, Adamec J, Sandusky GE, Dudhgaonkar. (2012) Mushroom Ganoderma lucidum prevents colitis-associated carcinogenesis in mice. PLoS ONE 2012. 7(10): e47873. |
[23] | Acharya K, Samui K, Rai M, Dutta BB, Acharya R. (2004) Antioxidant and nitric oxide synthase activation properties of Auricularia auricula. Indian J Exp Biol 42: 538-540. PMID: 15233483 |
[24] | Cai M, Lin Y, Luo Y, Liang H, Sun P. (2015) Extraction, antimicrobial, and antioxidant activities of crude polysaccharides from the wood ear medicinal mushroom Auricularia auricula-judae (Higher Basidiomycetes). Int J Med Mushrooms 17(6): 591-600. |
[25] | Borchers AT, Krishnamurthy A, Keen CL, Meyers FJ, Gershwin ME. (2008) The immunobiology of mushrooms. Exp Biol Med (Maywood) 233: 259-276. |
[26] | Kanaya N, Kubo M, Liu Z, Chu P, Wang C, Yuan YC, Chen S. (2011) Protective effects of white button mushroom (Agaricus bisporus) against hepatic steatosis in ovariectomized mice as a model of postmenopausal women. PLOS ONE 6(10): e26654. |
[27] | Chowdhury MMH, Kubra K, Ahmed SR. (2015) Screening of antimicrobial, antioxidant properties and bioactive compounds of some edible mushrooms cultivated in Bangladesh. Ann Clin Microbiol Antimicrob 14: 8. |
[28] | Yuan ZM, He PM, Cui JH, Takeuchi H. (1998) Hypoglycemic effect of water-soluble polysaccharides from Woody Ear (Auricularia auricula-judae Quel.) in genetically diabetic KK-Ay mice. J Nutr Sci Vitaminol 44(6): 829-840. |
[29] | Nowacka N, Nowak R, Drozd M, Olech M, Los R, Malm A. (2015) Antibacterial, antiradical potential and phenolic compounds of thirty-one Polish mushrooms. PLOS ONE 10(10): e0140355. |
[30] | Chang ST, Buswell JA. (2003) Medicinal Mushrooms - A Prominent Source of Nutraceuticals for the 21st century. Curr Top Nutraceutical Res 1: 257-280. |
[31] | Smolskaite L, Venskutonis PR, Talou T. (2015) Comprehensive evaluation of antioxidant and antimicrobial properties of different mushroom species. LWTFood Sci Technol 60: 462-471. |
[32] | Dehelean CA, Marcovici I, Soica C, Mioc M, Coricovac D, Iurciuc S, Cretu OM, Pinzaru I. (2021) Plant-Derived Anticancer Compounds as New Perspectives in Drug Discovery and Alternative Therapy. Molecules 26(4): 1109. |
[33] | Cragg G, Newman D. (2001) Nature’s bounty. Chemistry in Britain 37: 22-26 |
[34] | Hobbs C. (1995) In Medicinal Mushrooms: an exploration of tradition, healing and culture. Botanica press. Santa Cruz. Calif. |
[35] | Hobbs C. (2000) Medicinal value of Lentinus edodes (Berk.) Sing. (Agaricomycetideae). A Literature Review. International Journal of Medicinal Mushrooms 2: 287-302. |
[36] | Ray P, Kundu S, Paul, D. (2024) Exploring the Therapeutic Properties of Chinese Mushrooms with a Focus on their Anti-Cancer Effects: A Systemic review. Pharmacological Research - Modern Chinese Medicine. |
[37] | Baptista F, Campos J, Costa-Silva V, Pinto AR, Saavedra MJ, Ferreira LM, Rodrigues M, Barros AN. (2023) Nutraceutical Potential of Lentinula edodes’ Spent Mushroom Substrate: A Comprehensive Study on Phenolic Composition, Antioxidant Activity, and Antibacterial Effects. Journal of Fungi 9(12): 1200. |
[38] | Ekiz E, Oz E, Abd El-Aty AM, Proestos C, Brennan C, Zeng M, Tomasevic I, Elobeid T, Çadırcı K, Bayrak M, Oz F. (2023) Exploring the Potential Medicinal Benefits of Ganoderma lucidum: From Metabolic Disorders to Coronavirus Infections. Foods. 12(7): 1512. |
[39] | Wasser SP, Weis AL. (1999) Medicinal properties of substances occurring in Higher Basidiomycetes mushrooms: current perspectives. International Journal of Medicinal Mushroom.1: 31-62. |
[40] | Stamets P. (2000) In: Growing gourmet and medicinal mushrooms, 3rd edn. Ten Speed Press. Berkeley. Calif. |
[41] | Singh B, Singh VK. (2023c) Diversity of Wood-Inhabiting Macrofungi from District Ayodhya, Uttar Pradesh, India. Kavaka. 59(3): 2023. |
[42] | Singh B, Singh VK, Kumar S. (2024) A Survey of Macrofungal Diversity in the Ayodhya Region, Uttar Pradesh, India. Kavaka 60(1): 2024. |
[43] | Dar MA, Jyoti MC, Shaha M, Pandit RS. (2020) Impact of essential oils on Musca domestica larvae: oxidative stress and antioxidant responses. International Journal of Tropical Insect Science 41, 821-830. |
[44] | Sunday EA, Israel AU, Magu TO. (2016) Proximate analysis and mineral element composition of false yam (Icacina trichantha) tuber and oyster mushroom (Pleurotus ostreatus). Int. J. Chem. Sci. 11(11): 31-39. |
[45] | Miles LA, Lopera CA, Gonzalez S, Cepero de Garcia MC, Franco AE, Restrepo S. (2012) Exploring the biocontrol potential of fungal endophytes from an Andean Colombian Paramo ecosystem. Bio Control 57(5): 697-710. |
[46] | Kusari P, Kusari S, Spiteller M, Kayser O. (2013) Endophytic fungi harboured in Cannabis sativa L.: diversity and potential as biocontrol agents against host plant-specific phytopathogens. Fungal Diver 60: 137-151. |
[47] | Oyetayo VO, Dong CH, Yao YJ. (2009) Antimicrobial activity of the ethanol extract of the aerial parts of Sida acutaburm (Malvaceae). Trop J Pharm Res 6: 809-813. |
[48] | Fatima M, Dar MA, Dhanavade MJ, Abbas SZ, Bukhari MN, Arslan A, Liao Y, Wan J, Bukhari JS, Ouyang Z. (2024) Biosynthesis and pharmacological activities of the bioactive compounds of white mulberry (Morus alba): Current paradigms and future challenges. Biology 13(7): 506. |
APA Style
Singh, B., Dwivedi, S., Barwant, M. M., Singh, V. K., Singh, A. K., et al. (2024). Exploring the Antimicrobial Properties of Some Selective Mushroom Mycoflora. Chemical and Biomolecular Engineering, 9(4), 52-61. https://doi.org/10.11648/j.cbe.20240904.11
ACS Style
Singh, B.; Dwivedi, S.; Barwant, M. M.; Singh, V. K.; Singh, A. K., et al. Exploring the Antimicrobial Properties of Some Selective Mushroom Mycoflora. Chem. Biomol. Eng. 2024, 9(4), 52-61. doi: 10.11648/j.cbe.20240904.11
@article{10.11648/j.cbe.20240904.11, author = {Balwant Singh and Sneha Dwivedi and Mukul Machhindra Barwant and Vinay Kumar Singh and Alok Kumar Singh and Shailendra Kumar and Mudasir Ahmad Dar}, title = {Exploring the Antimicrobial Properties of Some Selective Mushroom Mycoflora }, journal = {Chemical and Biomolecular Engineering}, volume = {9}, number = {4}, pages = {52-61}, doi = {10.11648/j.cbe.20240904.11}, url = {https://doi.org/10.11648/j.cbe.20240904.11}, eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.cbe.20240904.11}, abstract = {Mushrooms have long been recognized for their nutritional and medicinal properties, but their potential as sources of antimicrobial agents remains underexplored. This study investigates the antimicrobial activity of various wild mushroom species against selected bacterial and fungal pathogens. Specifically, the study focused on the inhibition zones of Staphylococcus aureus, Escherichia coli, Candida albicans, Fusarium oxysporum, and Fusarium proliferatum when exposed to extracts from twelve different mushroom species, including Schizophyllum commune, Laeiporus sulphureus, Pleurotus pulmonarius, and others. The results revealed significant antibacterial and antifungal activities, with Schizophyllum commune showing the highest inhibition against Fusarium oxysporum (71.42 ± 0.28 mm) and Microporus xanthopus demonstrating strong inhibition against Staphylococcus aureus (8.46 ± 0.11 mm). Additionally, Pleurotus sajor-caju exhibited notable antifungal activity against Fusarium proliferatum (76.06 ± 0.14 mm), suggesting its potential as a source of novel antifungal compounds. The study observed a varied range of inhibition zones across different mushroom species, emphasizing the diverse antimicrobial potential within mushroom mycoflora. These findings underscore the importance of further research into the bioactive compounds of mushrooms, which could contribute to the development of new antimicrobial agents. The study not only highlights the significance of mushrooms in combating microbial resistance but also opens avenues for their inclusion in future pharmaceutical applications. }, year = {2024} }
TY - JOUR T1 - Exploring the Antimicrobial Properties of Some Selective Mushroom Mycoflora AU - Balwant Singh AU - Sneha Dwivedi AU - Mukul Machhindra Barwant AU - Vinay Kumar Singh AU - Alok Kumar Singh AU - Shailendra Kumar AU - Mudasir Ahmad Dar Y1 - 2024/12/25 PY - 2024 N1 - https://doi.org/10.11648/j.cbe.20240904.11 DO - 10.11648/j.cbe.20240904.11 T2 - Chemical and Biomolecular Engineering JF - Chemical and Biomolecular Engineering JO - Chemical and Biomolecular Engineering SP - 52 EP - 61 PB - Science Publishing Group SN - 2578-8884 UR - https://doi.org/10.11648/j.cbe.20240904.11 AB - Mushrooms have long been recognized for their nutritional and medicinal properties, but their potential as sources of antimicrobial agents remains underexplored. This study investigates the antimicrobial activity of various wild mushroom species against selected bacterial and fungal pathogens. Specifically, the study focused on the inhibition zones of Staphylococcus aureus, Escherichia coli, Candida albicans, Fusarium oxysporum, and Fusarium proliferatum when exposed to extracts from twelve different mushroom species, including Schizophyllum commune, Laeiporus sulphureus, Pleurotus pulmonarius, and others. The results revealed significant antibacterial and antifungal activities, with Schizophyllum commune showing the highest inhibition against Fusarium oxysporum (71.42 ± 0.28 mm) and Microporus xanthopus demonstrating strong inhibition against Staphylococcus aureus (8.46 ± 0.11 mm). Additionally, Pleurotus sajor-caju exhibited notable antifungal activity against Fusarium proliferatum (76.06 ± 0.14 mm), suggesting its potential as a source of novel antifungal compounds. The study observed a varied range of inhibition zones across different mushroom species, emphasizing the diverse antimicrobial potential within mushroom mycoflora. These findings underscore the importance of further research into the bioactive compounds of mushrooms, which could contribute to the development of new antimicrobial agents. The study not only highlights the significance of mushrooms in combating microbial resistance but also opens avenues for their inclusion in future pharmaceutical applications. VL - 9 IS - 4 ER -